Karyopharm Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 02/11/2025 | 7.65 M | $5.17 M | 0.00% | 6.12% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 6.32 M | $4.27 M | 46.30% | 5.06% |
| PALO ALTO INVESTORS LP | 02/14/2025 | 4.91 M | $3.32 M | -3.83% | 3.93% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3.77 M | $2.55 M | 3.59% | 3.01% |
| MARSHALL WACE, LLP | 02/13/2025 | 2.40 M | $1.63 M | 15.33% | 1.92% |
| 02/14/2025 | 2.33 M | $1.58 M | 100.00% | 1.87% | |
| EVERSEPT PARTNERS, LP | 02/14/2025 | 2.09 M | $1.41 M | -62.35% | 1.67% |
| AVIDITY PARTNERS MANAGEMENT LP | 02/14/2025 | 2.02 M | $1.37 M | 0.00% | 1.61% |
| GSA CAPITAL PARTNERS LLP | 02/07/2025 | 1.60 M | $1.08 M | -9.98% | 1.28% |
| C WORLDWIDE GROUP HOLDING A/S | 02/04/2025 | 1.50 M | $1.01 M | 0.00% | 1.20% |
| UBS OCONNOR LLC | 02/14/2025 | 1.48 M | $1.00 M | 24.04% | 1.19% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.39 M | $941,867 | 2.72% | 1.11% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.34 M | $903,382 | -0.07% | 1.07% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 1.31 M | $888,586 | -33.72% | 1.05% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 1.27 M | $862,768 | 0.00% | 1.01% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 1.20 M | $813,312 | -3.13% | 0.96% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2025 | 1.20 M | $808,377 | -0.72% | 0.96% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 1.15 M | $780,730 | -8.03% | 0.92% |
| JANE STREET GROUP, LLC | 02/14/2025 | 748,306 | $506,079 | 265.47% | 0.60% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 740,000 | $500,462 | 0.00% | 0.59% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 664,145 | $449,161 | 119.52% | 0.53% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2025 | 595,990 | $403,068 | 6.72% | 0.48% |
| MACQUARIE GROUP LTD | 02/14/2025 | 500,000 | $338,000 | 0.00% | 0.40% |
| BIRCHVIEW CAPITAL, LP | 02/14/2025 | 419,832 | $283,932 | -10.64% | 0.34% |
| FMR LLC | 02/13/2025 | 412,456 | $278,944 | 11.56% | 0.33% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 408,899 | $276,539 | -0.11% | 0.33% |
| UBS OCONNOR LLC | 02/14/2025 | 400,000 | $30,000 | 100.00% | 0.32% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 342,847 | $230,000 | -6.96% | 0.27% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 328,807 | $222,372 | -33.74% | 0.26% |
| JPMORGAN CHASE & CO | 02/12/2025 | 276,208 | $186,799 | -80.07% | 0.22% |
| ATOM INVESTORS LP | 02/14/2025 | 259,824 | $175,719 | 0.00% | 0.21% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 239,500 | $161,974 | 0.00% | 0.19% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 229,685 | $155,336 | -78.07% | 0.18% |
| EXCHANGE TRADED CONCEPTS, LLC | 01/21/2025 | 218,791 | $147,968 | 0.00% | 0.18% |
| SHAY CAPITAL LLC | 02/14/2025 | 172,153 | $116,427 | 100.00% | 0.14% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 166,317 | $112,481 | 0.00% | 0.13% |
| UBS GROUP AG | 02/14/2025 | 145,791 | $98,555 | 8.41% | 0.12% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 137,786 | $93,185 | 60.35% | 0.11% |
| WOODLINE PARTNERS LP | 02/14/2025 | 134,112 | $90,700 | 0.00% | 0.11% |
| OPTI CAPITAL MANAGEMENT, LP | 02/14/2025 | 125,000 | $84,538 | 100.00% | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 110,200 | $74,936 | -39.88% | 0.09% |
| CITIGROUP INC | 02/12/2025 | 105,679 | $71,471 | -0.01% | 0.08% |
| BARCLAYS PLC | 02/13/2025 | 95,611 | $65,000 | -0.16% | 0.08% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 90,635 | $61,296 | -0.50% | 0.07% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 02/14/2025 | 84,698 | $57,281 | 2.73% | 0.07% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 76,600 | $51,805 | 145.51% | 0.06% |
| PRUDENTIAL FINANCIAL INC | 02/11/2025 | 74,600 | $50,452 | 0.00% | 0.06% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 64,300 | $44,000 | -52.26% | 0.05% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 51,173 | $34,608 | 0.34% | 0.04% |
| TD WATERHOUSE CANADA INC. | 02/13/2025 | 48,049 | $32,193 | 100.00% | 0.04% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Karyopharm Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 139 institutional investors and hedge funds held shares of Karyopharm Therapeutics Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 7.65 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 6.32 M
Palo Alto Investors LP: 4.91 M
BlackRock Funding, Inc. /DE: 3.77 M
MARSHALL WACE, LLP: 2.4 M
Eversept Partners, LP: 2.09 M
48.72% of Karyopharm Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 65.52 M shares in the last 24 months. This purchase volume represents approximately $54.38 M in transactions.